Breaking News Instant updates and real-time market news.

NEE

NextEra Energy

$190.53

1.21 (0.64%)

, UTX

United Technologies

$136.99

-0.01 (-0.01%)

20:25
04/22/19
04/22
20:25
04/22/19
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Procter & Gamble (PG), consensus $1.03... Verizon Communications (VZ), consensus $1.17... Coca-Cola (KO), consensus 46c... United Technologies (UTX), consensus $1.71... NextEra Energy (NEE), consensus $1.92... Lockheed Martin (LMT), consensus $4.34... Sherwin-Williams (SHW), consensus $3.69... Twitter (TWTR), consensus 15c... State Street (STT), consensus $1.19... Centene (CNC), consensus $1.34... Fifth Third Bancorp (FITB), consensus 58c... Nucor (NUE), consensus $1.50... Quest Diagnostics (DGX), consensus $1.36... Hasbro (HAS), consensus (10c)... Harley-Davidson (HOG), consensus 65c... Polaris Industries (PII), consensus 91c... JetBlue (JBLU), consensus 12c... Graphic Packaging (GPK), consensus 18c.

NEE

NextEra Energy

$190.53

1.21 (0.64%)

UTX

United Technologies

$136.99

-0.01 (-0.01%)

KO

Coca-Cola

$47.38

-0.11 (-0.23%)

VZ

Verizon

$58.38

0.33 (0.57%)

PG

Procter & Gamble

$106.04

-0.01 (-0.01%)

LMT

Lockheed Martin

$315.24

0.94 (0.30%)

SHW

Sherwin-Williams

$451.83

-0.61 (-0.13%)

TWTR

Twitter

$34.39

-0.01 (-0.03%)

STT

State Street

$69.92

-0.02 (-0.03%)

CNC

Centene

$48.19

0.04 (0.08%)

FITB

Fifth Third

$27.54

0.02 (0.07%)

NUE

Nucor

$57.00

-0.49 (-0.85%)

DGX

Quest Diagnostics

$85.17

-0.55 (-0.64%)

HAS

Hasbro

$88.02

-0.72 (-0.81%)

HOG

Harley-Davidson

$39.71

-1.2 (-2.93%)

PII

Polaris Industries

$98.93

0.185 (0.19%)

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

GPK

Graphic Packaging

$12.98

0.035 (0.27%)

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 29

    Apr

  • 02

    May

  • 02

    May

  • 02

    May

  • 04

    May

  • 07

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 14

    May

  • 15

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 20

    May

  • 20

    May

  • 22

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 11

    Jun

  • 12

    Jun

  • 23

    Jun

  • 13

    Nov

NEE NextEra Energy
$190.53

1.21 (0.64%)

04/08/19
GSCO
04/08/19
NO CHANGE
GSCO
Goldman Sachs more cautious on Utilities due to 'stretched valuations'
Goldman Sachs analysts Michael Lapides and Insoo Kim are more cautious on Americas Utilities due to "stretched valuations" across the utility sector. The analysts now see negative 2% total return across their utilities coverage. Following the Utilities SPDR (XLU) ~11% outperformance versus the S&P 500 since the start of Q4 2018, the group now trades at a 20% premium to the market, Lapides and Kim tells investors in a research note. The analysts removed NextEra Energy (NEE) from their firm's Conviction List but remain Buy-rated, upgraded NiSource (NI) to Buy from Neutral on less uncertainty regarding the Greater Lawrence incident, upgraded OGE Energy (OGE) to Neutral from Sell on valuation, downgraded WEC Energy (WEC) to Sell from Neutral, upgraded Avangrid (AGR) to Neutral from Sell, and downgraded American Electric Power (AEP) to Neutral from Buy.
04/08/19
GSCO
04/08/19
DOWNGRADE
GSCO
Buy
NextEra Energy downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Michael Lapides removed NextEra Energy to his firm's America's Conviction List while maintaining a Buy rating on the shares.
03/31/19
GSCO
03/31/19
UPGRADE
Target $49
GSCO
Buy
Goldman upgrades NextEra Energy Partners to Buy on distribution growth
Goldman Sachs analyst Michael Lapides upgraded NextEra Energy Partners (NEP) to Buy from Neutral and raised his price target for the shares to $49 from $45. The analyst sees visibility into more than 10 years of double digit distribution growth for the company. He expects NextEra Energy (NEE) to maintain its U.S. renewable market share in an industry growing at an over 9% annually through 2030. And he expects NextEra Energy Partners to leverage its "favorable" balance sheet position to only require minimal equity through 2021 to finance drop-downs. NextEra Energy Partners appears positioned to continue growing distributions at the upper end of the 12%-15% guidance range beyond the next five years, Lapides tells investors in a research note. The analyst believes the company's reduced dividend growth risk and long-term visibility is not fully appreciated at current share levels.
03/20/19
LEHM
03/20/19
NO CHANGE
LEHM
Barclays upgrades NextEra and FirstEnergy, downgrades NorthWestern
Barclays analyst Eric Beaumont upgraded both NextEra Energy (NEE) and FirstEnergy (FE) to Overweight from Equal Weight while downgrading NorthWestern (NWE) to Underweight from Equal Weight. The rating changes reflect the analyst's updated valuations based on 2021 estimates combined with price performance over the past quarter. On NextEra, he believes "top industry growth" combined with an above-average regulatory environment will drive the valuation. FirstEnergy currently looks like a "deep value or show-me story," but with a transformative 2018 behind it, execution on the story in 2019 will be the key driver to stock performance, Beaumont tells investors in a research note. For NorthWestern, the analyst thinks the stock is discounting too optimistic of an outcome for the Montana rate case.
UTX United Technologies
$136.99

-0.01 (-0.01%)

03/13/19
MSCO
03/13/19
NO CHANGE
MSCO
Morgan Stanley says 737 MAX grounding shouldn't hurt long-term fundamentals
Morgan Stanley analyst Rajeev Lalwani noted that most major countries and airlines that operate Boeing's (BA) 737 MAX, except for the U.S. and Canada, have placed restrictions around the plane and his expectation is for a grounding of the fleet globally. In that base case, he said there is likely to be disruption to Boeing's deliveries and order activity that ultimately create a buying opportunity over the coming quarters as he thinks the issue should not impact fundamentals in the long run. In regard to suppliers such as Spirit AeroSystems (SPR) and United Technologies (UTX), Lalwani believes disruption will be limited, contrary to market reactions. Among U.S. airlines who operate the 737 MAX, Lalwani said Southwest (LUV) screens as most exposed versus American Airlines (AAL) and United Continental (UAL). For aircraft lessors like Air Lease (AL) and AerCap (AER), a global grounding scenario has "mixed implications," added the analyst. Though he remains comfortable with his Overweight rating and $500 price target on Boeing shares, Lalwani thinks clarity on the path ahead for the 737 will be needed for shares to resume their upward trend.
04/04/19
MSCO
04/04/19
NO CHANGE
MSCO
U.S. HVAC may be at 'now or never' moment for consolidation, says Morgan Stanley
Morgan Stanley analysts Joshua Pokrzywinski and Rajeev Lalwani said they believe the U.S. heating, ventilation, and air conditioning industry may be at a "now or never" moment for consolidation, noting that United Technologies (UTX) has started "negotiating in public" given CEO Greg Hayes' comments on his view on valuation, timing and a structure for any deal for its Carrier business. The analysts said they believe that antitrust concerns limit the discussion to two potential transactions, namely combining Carrier with Johnson Controls (JCI) or with Lennox (LII). While both scenarios could unlock value, they view the path to a deal as easier for Lennox and see United Technologies shares as "the best way to play" this consolidation theme. Including a Carrier transaction in their sum-of-the-parts valuation would point to a United Technologies share price of up to $170, versus their price target on the stock of $155, noted the analysts.
02/22/19
02/22/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nvidia (NVDA) initiated with an Overweight at Atlantic Equities. 2. United Technologies (UTX) resumed with an Overweight at JPMorgan. 3. Wabtec (WAB) initiated with a Hold at Jefferies. 4. STMicroelectronics (STM) initiated with an Outperform at Cowen. 5. Biogen (BIIB) initiated with a Market Perform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/22/19
JPMS
02/22/19
INITIATION
Target $132
JPMS
Overweight
United Technologies resumed with an Overweight at JPMorgan
JPMorgan analyst Stephen Tusa resumed United Technologies with an Overweight rating and $132 price target following a period of restriction. The company's investment phase is "now driving top tier, visible organic growth," Tusa tells investors in a research note. With United Technologies' backlog/services providing "stability in a potential downturn scenario," the analyst sees a favorable risk/reward profile for the shares.
KO Coca-Cola
$47.38

-0.11 (-0.23%)

03/29/19
WELS
03/29/19
NO CHANGE
WELS
Coca-Cola energy drink launch in Europe negative for Monster, says Wells Fargo
Coca-Cola (KO) yesterday announced plans to launch its first ever energy drink in Europe, Wells Fargo analyst Bonnie Herzog tells investors in a research note titled "KO Unleashes Its Own 'Monster' with Coke Energy in Europe." Importantly, the announcement came despite the fact that Coca-Cola's ongoing arbitration with Monster Beverage (MNST) has not concluded, says the analyst. She believes this "clearly signals" that Coca-Cola is increasingly confident that it will prevail in the arbitration process. Herzog views the development as a negative for Monster "given that a Coca-Cola-branded energy drink represents yet another source of competition." She thinks the risks are increasing for Market Perform-rated Monster "from multiple vantage points" and maintains his cautious view on the stock.
03/12/19
03/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boeing (BA) downgraded to Hold from Buy at Edward Jones. 2. Monster Beverage (MNST) downgraded to Market Perform from Outperform at BMO Capital with analyst Amit Sharma saying Monster's current valuation, both absolute and relative to peers, "may be as good it gets." 3. Coca-Cola (KO) downgraded to Hold from Buy at HSBC with analyst Carlos Laboy saying in "trying to grow the pie," Coke is being required to drive revenues with low-margin brands that may take years to scale up. 4. HP Enterprise (HPE) downgraded to Sell from Neutral at UBS with analyst John Roy saying the company's on-premises hardware sales are being pressured by the growth in public cloud, while the "stock is expecting better." 5. F5 Networks (FFIV) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying the "expensive" acquisition of NGINX is "tough to digest" given the integration and execution risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/12/19
HSBC
03/12/19
DOWNGRADE
Target $50
HSBC
Hold
Coca-Cola downgraded to Hold on valuation, bottler challenges at HSBC
As previously reported, HSBC analyst Carlos Laboy downgraded Coca-Cola to Hold from Buy, stating that in "trying to grow the pie," Coke is being required to drive revenues with low-margin brands that may take years to scale up. If the "brands that pay the bills" hardly grow and the ones that grow aren't profitable enough, "convincing bottlers to believe" gets harder, said the analyst, who contends that "if the bottlers aren't happy, nobody's happy." The analyst, who also cites valuation given Coca-Cola's new flat EPS guidance, lowered his price target on Coke shares to $50 from $64.
04/11/19
MSCO
04/11/19
DOWNGRADE
Target $24
MSCO
Underweight
Morgan Stanley downgrades Keurig Dr Pepper to Underweight on coffee risk
As previously reported, Morgan Stanley analyst Dara Mohsenian downgraded Keurig Dr Pepper to Underweight from Equal Weight as he sees a negative risk-reward despite a "well telegraphed" Q1 earnings beat on strong pricing at heritage Dr. Pepper Snapple. Based on the firm's recent AlphaWise survey, the analyst sees risk to coffee growth, noting that his forecast of around 1.5% is below the market-implied 4% long-term coffee topline growth, which is a key driver of his EPS forecast by 2021 being 5% below consensus. Additionally, Keurig Dr Pepper shares trade at a premium to the average of beverage peers Coca-Cola (KO) and PepsiCo (PEP) despite lower expected long-term topline growth, Mohsenian noted. He cut his price target on Keurig Dr Pepper shares to $24 from $27.
VZ Verizon
$58.38

0.33 (0.57%)

01/29/19
01/29/19
DOWNGRADE

Hold
Adtran downgraded to Hold at Needham on margin pressure
As previously reported, Needham analyst Richard Valera downgraded Adtran to Hold from Buy, saying that while the company posted solid Q4 results, the quarter was aided "by the re- emergence of Telmex" and warns that its shift toward international business will results in "structurally lower margins" and limited earnings power. The analyst further notes that he had previously anticipated AT&T (T) and Verizon (VZ) deals as "potentially significant" North America revenue opportunities, but now sees "little confidence either of these programs will ramp substantially over the near to medium term." Valera adds that the recent bounce in Adtran stock has taken its price to within 10% of his prior target, justifying a neutral stance.
02/22/19
WELS
02/22/19
NO CHANGE
Target $65
WELS
Outperform
Verizon has network focus in its 'DNA,' says Wells Fargo
After attending Verizon's analyst day centered around the company's "very detailed 5G strategy," Wells Fargo analyst Jennifer Fritzsche noted that there were a lot of new faces on the stage compared to five years ago but she said the company "appreciates the network is THE # 1 focus" and "that network focus...is fully in this company's DNA it seems." The analyst, who favors the way Verizon is "doubling down on what it knows best," namely the network, left the meeting with confidence a 5G plan is in place. She keeps an Outperform rating on Verizon shares and raised her price target on the stock to $65 from $60.
02/22/19
MSCO
02/22/19
NO CHANGE
Target $58
MSCO
Equal Weight
5G financial impact won't be felt by Verizon until 2021/22, says Morgan Stanley
After attending Verizon's first analyst day in seven years, Morgan Stanley analyst Simon Flannery said the company provided "a lot of helpful material" on its 5G plans, but provided limited incremental information around deployment timelines or business models. The analyst, said it seems that the financial impact of 5G will not be felt by Verizon until the 2021/22 period, also said that it appears to him that operational momentum from 2018 is continuing into 2019. Flannery maintains an Equal Weight rating on Verizon with a $58 price target on the shares.
04/17/19
GSCO
04/17/19
NO CHANGE
GSCO
Sprint, T-Mobile headlines positive for Dish, Intelsat, says Goldman Sachs
Goldman Sachs analyst Brett Feldman, while taking no view on the outcome of the proposed merger between Sprint (S) and T-Mobile (TMUS), laid out his thoughts for other industry participants following the Wall Street Journal's report that the Department of Justice is unlikely to approve the deal as currently structured. The analyst believes investors will initially see the headlines as negative for the other major wireless carriers, namely AT&T (T) and Verizon (VZ), since they "create uncertainty over long-term industry structure." Further, investors will initially see these headlines as a slight positive for tower operators American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC) as they "imply less risk of material cell site decommissioning," Feldman told investors earlier in a research note. The analyst also thinks investors will view the Journal's report as positive for owners of excess spectrum such as Dish (DISH) and Intelsat (I) and a slight positive for cable operators like Altice USA (ATUS), Charter (CHTR) and Comcast (CMCSA).
PG Procter & Gamble
$106.04

-0.01 (-0.01%)

03/07/19
03/07/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Five Below (FIVE) initiated with an Outperform at Oppenheimer. 2. Teva (TEVA) reinstated with a Buy at UBS. 3. Chiasma (CHMA) initiated with an Overweight at Cantor Fitzgerald. 4. Monster Beverage (MNST) and Constellation Brands (STZ) were initiated with an Outperform at Credit Suisse, while Procter & Gamble (PG), Coca-Cola (KO), and Church & Dwight (CHD) were initiated with a Neutral, and PepsiCo (PEP), Colgate-Palmolive (CL), and Clorox (CLX) initiated with an Underperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/08/19
WELS
04/08/19
UPGRADE
WELS
Outperform
Procter & Gamble upgraded to Outperform from Market Perform at Wells Fargo
04/08/19
WELS
04/08/19
UPGRADE
Target $115
WELS
Outperform
Procter & Gamble upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Bonnie Herzog upgraded Procter & Gamble to Outperform from Market Perform and raised her price target to $115 from $91, telling investors that while she is "late to the game," she still sees upside and believes P&G has changed and management, led by CEO David Taylor, has infused a sense of urgency and accountability into the organization. Herzog says that while it "took awhile" for consistent results to show, fundamentals appear to have turned, and sees a potential upside surprise in the third quarter on both the top and bottom line. She also views P&G as one of the few Staples companies that will be able to consistently deliver accelerating organic sales growth while expanding margins at the same time.
04/08/19
04/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wynn Resorts (WYNN) upgraded to Buy from Hold at Jefferies with analyst David Katz citing better than expected gross gaming revenue results from Macau for March and signs that suggest to him that it is reasonable to expect economic improvement throughout 2019 in China. 2. e.l.f. Beauty (ELF) upgraded to Neutral from Underweight at JPMorgan. 3. Procter & Gamble (PG) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog telling investors that while she is "late to the game," she still sees upside and believes P&G has changed and management, led by CEO David Taylor, has infused a sense of urgency and accountability into the organization. 4. AMC Entertainment (AMC) upgraded to Buy from Neutral at B. Riley FBR with analyst Eric Wold saying he has an "increasingly optimistic" view of the EBITDA contribution from Stubs A-List. 5. Zillow (Z, ZG) upgraded to Outperform from Market Perform at Cowen with analyst Thomas Champion saying he believes the new duo of CEO Rich Barton and CFO Allen Parker look well suited for the "massive challenge" of leading the company through a change in business model. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LMT Lockheed Martin
$315.24

0.94 (0.30%)

01/10/19
01/10/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ship Finance (SFL) initiated with a Neutral at B. Riley FBR. 2. Wipro (WIT) initiated with a Hold at Deutsche Bank. 3. Boeing (BA), Lockheed Martin (LMT), and Raytheon (RTN) were initiated with a Positive at Susquehanna while Northrop Grumman (NOC) and General Dynamics (GD) were initiated with a Neutral. 4. Dollar General (DG) initiated with an Outperform at BMO Capital while Dollar Tree (DLTR) was initiated with a Market Perform. 5. Verint (VRNT) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/19
01/10/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) downgraded to Equal Weight from Overweight at Morgan Stanley. 2. JetBlue (JBLU) downgraded to Neutral from Overweight at JPMorgan with analyst Jamie Baker lowering his price target for the shares to $18 from $20. 3. Weatherford (WFT) downgraded to Market Perform from Outperform at BMO Capital with analyst Daniel Boyd saying the stock represents a "call-option on the oil cycle," but sees that option "suffering from time decay" and an adverse macro environment. 4. Yelp (YELP) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Brian Nowak saying he identified three building revenue headwinds that he believes will lead to negative revisions and underperformance of the stock. 5. Dollar Tree (DLTR) downgraded to Perform from Outperform at Oppenheimer with analyst Rupesh Parikh saying he now views shares as fully valued and sees the case for upside as less attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/19
01/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Constellation Brands (STZ) upgraded to Buy from Neutral at Goldman Sachs and to Neutral from Sell at Guggenheim. 2. Boeing (BA) upgraded to Overweight from Equal Weight at Morgan Stanley. 3. Lockheed Martin (LMT) upgraded to Buy from Hold at Vertical Group. 4. United Continental (UAL) upgraded to Overweight from Neutral at JPMorgan while Alaska Air (ALK) was upgraded to Neutral from Underweight. 5. Twitter (TWTR) double upgraded to Buy from Underperform at BofA/Merrill with analyst Justin Post citing a survey he conducted which showed Twitter penetration increased to 48% of respondents and the percentage of users reporting deceased usage fell slightly. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/19
SUSQ
01/10/19
INITIATION
Target $321
SUSQ
Positive
Lockheed Martin initiated with a Positive at Susquehanna
Susquehanna analyst Charles Minervino initiated Lockheed Martin with a Positive rating as he believes it should be a prime beneficiary of strong global defense spending. He expects its earnings growth will drive free cash flow generation in the coming years, providing opportunities for additional dividend increases, debt reduction, share repurchases and potential acquisitions. Minervino has a $321 price target on Lockheed Martin shares.
SHW Sherwin-Williams
$451.83

-0.61 (-0.13%)

03/22/19
JPMS
03/22/19
DOWNGRADE
Target $435
JPMS
Neutral
Sherwin-Williams downgraded to Neutral on valuation at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Sherwin-Williams to Neutral from Overweight with an unchanged price target of $435. With the stock near this target, the analyst downgrades the company on valuation. Sherwin is a high-quality company that trades at multiples that are among the highest in the coatings universe, Zekauskas tells investors in a research note.
03/22/19
03/22/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PPG (PPG) downgraded to Underweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying PPG shares have been drifting higher in 2019 as the market continues to prefer higher quality and less cyclical materials companies, however general economic business conditions are "arguably weaker than they have been because of decreased rates of economic growth in China and in Europe." 2. Sherwin-Williams (SHW) downgraded to Neutral from Overweight at JPMorgan with analyst Jeffrey Zekauskas citing valuation. 3. Booking Holdings (BKNG) downgraded to Neutral from Outperform at Wedbush with analyst James Hardiman stating that he believes the company's dominant position in Europe will be favorable in the long term, but is likely to represent a liability in 2019 as it is could amplify risks of earnings revisions and multiple compression. 4. Biogen (BIIB) downgraded to Underweight from Overweight at Morgan Stanley with analyst Matthew Harrison citing the failure of two Alzheimer's disease trials and noting that his optimism on Alzheimer's was "completely wrong." 5. Lululemon (LULU) downgraded to Neutral from Outperform at Wedbush with analyst Jen Redding saying that while she continues to see lululemon as best in class among specialty retailers, she is moving to the sidelines in anticipation of potentially less margin upside ahead, based on insights from proprietary data products. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/19
EVER
03/20/19
INITIATION
Target $495
EVER
Outperform
Sherwin-Williams initiated with an Outperform at Evercore ISI
Evercore ISI analyst Greg Melich started Sherwin-Williams with an Outperform rating and $495 base case price target, calling its controlled distribution, loyal contractor base, pricing power, and Valspar merger synergies "positives that shouldn't be overlooked."
03/22/19
JPMS
03/22/19
DOWNGRADE
Target $435
JPMS
Neutral
Sherwin-Williams downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Sherwin-Williams to Neutral from Overweight with an unchanged price target of $435.
TWTR Twitter
$34.39

-0.01 (-0.03%)

04/18/19
WEDB
04/18/19
NO CHANGE
Target $37
WEDB
Neutral
Twitter Q1 results expected at high end of guidance range, says Wedbush
Wedbush analyst Michael Pachter expects Twitter to report Q1 results at the high end of the guidance range, with no meaningful change to outlook. Twitter appears to be making progress toward sustainable revenue growth and margin expansion, he acknowledges. But given uncertainty over user growth, relatively "unimpressive" mDAU levels, and relatively rich valuation, Pachter reiterates a Neutral rating and a $37 price target on the shares.
04/22/19
BARD
04/22/19
NO CHANGE
Target $33
BARD
Neutral
Twitter to meet or beat Q1 revenue estimates, says Baird
Baird analyst Colin Sebastian expects Twitter tomorrow morning to meet or beat Q1 revenue expectations "given what appeared to be conservative guidance." Further, digital marketing trends in the quarter were stable, Sebastian tells investors in a pre-earnings research note. The analyst thinks Twitter will report Q1 revenue in line or above the high end of management's guidance range, driven by "healthy" monthly daily active user trends of up 9% year-over-year. Sebastian keeps a Neutral rating on the shares with a $33 price target.
04/22/19
CLVD
04/22/19
NO CHANGE
CLVD
Neutral
Twitter ad spending remains 'encouraging,' says Cleveland Research
Cleveland Research analyst Chandler Converse says his firm's research suggests that advertising spending on Twitter remains "encouraging." The analyst sees "strong" ad engagements and like-for-like growth after budgets, according to his firm's work, finished in-line with consensus expectations and at the high-end of Twitter's Q1 guidance. He continues to expect above-consensus advertising revenue for Twitter in 2019 on "strong execution with partners." Converse has a Neutral rating on the shares.
04/22/19
JEFF
04/22/19
NO CHANGE
JEFF
Jefferies still prefers Facebook in social, calls Twitter 'reasonably valued'
Social stocks have outperformed year-to-date, up ~55% versus the Nasdaq's rally of 20%, with Snap (SNAP) being the top performer up 120% after lagging the group in 2018, Jefferies analyst Brent Thill tells investors in a research note. The analyst continues to prefer share of Facebook (FB) in social with a Buy rating and $200 price target. He sees upside in average revenue per user and operating expenditure growth. Meanwhile, Thill is "incrementally positive" on Snap's "encouraging momentum," but says the company is "not out of the woods yet." If Snap can deliver on daily active user growth in Q1 it should be a catalyst for shares, however with the stock trading at nine-times 2019, these improvements are largely priced in, Thill tells investors in a pre-earnings research note. And while the analyst remains "fundamental fans" of Twitter, he views the stock as "reasonably valued." Further, Twitter faces tough comps for international in the first half of 2019 and for the U.S. in the second half of the year, Thill points out.
STT State Street
$69.92

-0.02 (-0.03%)

03/14/19
DBAB
03/14/19
DOWNGRADE
DBAB
Hold
State Street downgraded to Hold from Buy at Deutsche Bank
03/15/19
03/15/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Oracle (ORCL) downgraded to Market Perform from Outperform at BMO Capital with analyst Keith Bachman saying he believes Oracle can sustain ~2% constant currency revenue growth, but is "dubious" the company can improve its revenue growth rates. 2. Zillow (ZG, Z) downgraded to Underweight from Equal Weight at Barclays with analyst Deepak Mathivanan citing his expectations for a "material erosion" in unit economics in its Homes division, the operational challenges facing the company in buying, fixing up, and selling homes at scale and the fact that he thinks the company's efforts to slowly transition its core PA business closer to transaction will keep revenue growth muted in the near-term. 3. State Street (STT) downgraded to Hold from Buy at Deutsche Bank with analyst Brian Bedell saying he no longer sees any near- or intermediate-term positive catalysts for the stock given the likely continued revenue growth pressures this year. 4. Live Nation (LYV) downgraded to Neutral from Buy at Citi with analyst Jason Bazinet saying he continues to like Live Nation's business model and long-term growth prospects, but he views the valuation as "full" at current share levels. 5. Adobe (ADBE) downgraded to Sector Weight from Overweight at KeyBanc with analyst Brent Bracelin citing the company's fiscal Q1 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/19
DBAB
03/14/19
DOWNGRADE
Target $70
DBAB
Hold
State Street downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Brian Bedell downgraded State Street to Hold and lowered his price target to $70 from $84, saying he no longer sees any near- or intermediate-term positive catalysts for the stock given the likely continued revenue growth pressures this year. The analyst cites "flat-to-negative average market levels, pricing pressure in asset servicing, weak volumes in FX trading / securities lending, outflows in active products, and stable net interest revenue with mild net interest margin expansion offsetting slightly lower deposit levels." Bedell also believes that State Street shares will trade in a range near current levels for the balance of the year.
02/24/19
KBWI
02/24/19
DOWNGRADE
Target $70
KBWI
Underperform
State Street downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanz downgraded State Street to Underperform and lowered his price target for the shares to $70 from $72.
CNC Centene
$48.19

0.04 (0.08%)

04/05/19
COWN
04/05/19
NO CHANGE
COWN
Centene, Molina could be 'compelling' targets for Humana, says Cowen
Cowen analyst Charles Rhyee said he believes Centene's (CNC) planned takeover of WellCare (WCG) could potentially accelerate Humana's (HUM) timeline to acquire a scaled Medicaid asset, noting that it currently has the second smallest Medicaid book among managed care organizations. His analysis suggests Centene and Molina Healthcare (MOH) could both be "compelling acquisition targets" for Humana and believes the company has the financial capacity to make a bid for either, though Rhyee added that he does not believe Humana needs to rush a decision. Rhyee sees about a one year window in which Humana "can dictate the Medicaid M&A market" before Cigna (CI) and/or CVS Health (CVS) can get involved, he tells investors. While the analyst believes Centene makes the most sense as a potential target for Humana if the latter does not win the Texas STAR+PLUS contract, he suspects Centene is not willing to sell and believes Humana would have to offer a significant premium. If Humana does win the Texas STAR+PLUS contract it does not need to pursue large scale M&A, but a deal could be attractive anyway, Rhyee said.
04/10/19
RHCO
04/10/19
NO CHANGE
RHCO
SunTrust lowers price targets on CVS, raises price target on WellCare
SunTrust analyst David MacDonald lowered his price target on CVS (CVS) to $65 from $85 as part of his broader research note previewing Q1 results for the healthcare services stocks. The analyst expects the quarter to reflect the company's challenges around reimbursement pressure, fewer generics, and lower brand inflation that should be a detriment to retail pharmacy and long-term-care businesses, even though he maintains a bullish view on the stock longer term based on its risk-reward profile. MacDonald also raises his price target on WellCare (WCG) to $340 from $305, saying his bullish expectation for the stock is driven by the company's "strong core trends, high visibility, and superb win rate". The analyst also cites the pending WellCare acquisition by Centene (CNC) yielding a "meaningful combined pharmacy opportunity and increased diversification" from an expanded "Medicaid footprint".
04/15/19
FBCO
04/15/19
INITIATION
Target $307
FBCO
Neutral
WellCare initiated with a Neutral at Credit Suisse
Credit Suisse analyst A.J. Rice started coverage of WellCare (WCG) with a Neutral rating and a $307 price target. While the analyst forecasts WellCare growing revenue and EPS by roughly 29% and 22% this year, with revenue of more than $26B and EPS reaching $13.35, he believes the pending Centene (CNC) deal limits upside over near to immediate term.
04/17/19
SPHN
04/17/19
NO CHANGE
SPHN
Issues facing healthcare sector now 'modest' compared to 2008-10, says Stephens
Stephens analyst Scott Fidel noted that the managed care group has sharply underperformed the S&P 500 over the last month amid "political rhetoric" around point-of-sale drug rebates and Medicare for all policy proposals, though he believes the issues facing the sector right now "seem modest in comparison" to the "dark days of 2008-2010." While recent Medicare for all proposals have rattled investors, "they will face enormous uphill battles," Fidel tells investors. Hospital stocks have outperformed MCOs year-to-date, but the group declined about 9% yesterday and underperformed the MCO group, which Fidel attributes to acknowledgement by industry bellwether UnitedHealth (UNH) of the significant disruptive nature of Medicare for all, which may have sparked additional fears, as well as one less calendar day being called out by UnitedHealth as benefiting Q1 MLRs and Johnson & Johnson's (JNJ) earnings call commentary on declining sequential hospital admissions from Q4. Publicly traded companies in the hospital space include Community Health (CYH), HCA Healthcare (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS). Publicly traded companies in the managed care space include Anthem (ANTM), CVS Health (CVS), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
FITB Fifth Third
$27.54

0.02 (0.07%)

04/17/19
JEFF
04/17/19
DOWNGRADE
Target $84
JEFF
Hold
Comerica downgraded to Hold from Buy at Jefferies
Jefferies analyst Kenneth Usdin downgraded Comerica (CMA) to Hold from Buy with an unchanged price target of $84. Following negative earnings revisions post the company's Q1 results, the analyst does not see enough upside to warrant a Buy rating. Comerica's net interest income outlook is "proving even more challenging," with another deposit cost increase in March weighing most on forward estimates, Usdin tells investors in a research note. He prefers putting new money to work into Fifth Third Bancorp (FITB) for exposure to the regional banks.
04/04/19
KBWI
04/04/19
UPGRADE
Target $32
KBWI
Outperform
Fifth Third upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Klock upgraded Fifth Third Bancorp to Outperform from Market Perform with an unchanged price target of $32.
04/01/19
JEFF
04/01/19
NO CHANGE
JEFF
Jefferies upgrades Fifth Third, Wintrust to Buy, downgrades First Horizon
Jefferies analyst Ken Usdin upgraded both Fifth Third (FITB) and Wintrust Financial (WTFC) to Buy from Hold while downgrading First Horizon National (FHN) to Hold from Buy. Banks head into Q1 earnings season with a "complicated, but more attractive, set-up," Usdin tells investors in a research note. He believes negative earnings revisions based on the flatter curve will be "offset somewhat" by strong credit metrics. The analyst upgraded Fifth Third and raised his price target for the shares to $30 from $29 on earnings upside potential post the MB Financial deal close. Usdin upgraded Wintrust while lowering his price target for the shares to $77 from $78. He sees an attractive entry point following the recent underperformance. Usdin downgraded First Horizon and lowered his price target for the shares to $14 from $16.50 as he sees "meaningful" earnings revision risk.
04/01/19
JEFF
04/01/19
UPGRADE
JEFF
Buy
Fifth Third upgraded to Buy from Hold at Jefferies
NUE Nucor
$57.00

-0.49 (-0.85%)

03/18/19
STPT
03/18/19
UPGRADE
STPT
Buy
Nucor upgraded to Buy from Hold at Standpoint Research
03/11/19
03/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JetBlue (JBLU) downgraded to Equal Weight from Overweight at Barclays with analyst Brandon Oglenski lowering his price target for the shares to $20 from $27. 2. Nucor (NUE) downgraded to Neutral from Buy at Longbow with analyst Chris Olin saying his carbon steel market checks indicate muted demand growth for all major products, with negative momentum most apparent for plate, merchant bar and SBQ. 3. Oracle (ORCL) downgraded to Reduce from Buy at Nomura Instinet with analyst Christopher Eberle saying Oracle's buyback program has helped drive the stock to near all-time highs, but the rate of $10B in buybacks per quarter "can't last forever." 4. Greenbrier (GBX) and Trinity Industries (TRN) downgraded to Sector Weight from Overweight at KeyBanc. 5. Zumiez (ZUMZ) downgraded to Hold from Buy at Pivotal Research with analyst Mitch Kummetz saying the stock's risk/reward is no longer compelling after bouncing 40% off the mid-December lows. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/11/19
03/11/19
DOWNGRADE

Neutral
Nucor downgraded to Neutral on limited earnings visibility at Longbow
As previously reported, Longbow downgraded Nucor to Neutral from Buy. Analyst Chris Olin's carbon steel market checks indicate muted demand growth for all major products, with negative momentum most apparent for plate, merchant bar and SBQ. Further, there has been a "tepid" response to the sheet and rebar price increase announcements, the analyst wrote in a note to investors. Olin lowered Nucor's full year estimate to better reflect only a partial acceptance of recent mill price increases, rising material costs, and a modest contraction in mini-mill metal spreads and expects management to lower the current year estimate to better reflect increased risks.
03/19/19
JPMS
03/19/19
NO CHANGE
JPMS
JPMorgan cuts steel estimates on 'steeper than expected' price decline
JPMorgan analyst Michael Gambardella lowered his 2019 estimates for AK Steel (AKS), Nucor (NUE), Steel Dynamics (STLD) and U.S. Steel (X) to reflect the "steeper than expected" price decline for steel sheet prices in Q4 of 2018 and the lagged impact on Q1 of 2019. However, the analyst believes prices have bottomed and he sees improving steel prices going into Q2. Demand remains solid, and global iron ore prices have moved higher along with U.S. scrap prices, Gambardella tells investors in a research note. He keeps an Overweight rating on all four names while lowering his price target for Nucor to $81 from $83, for Steel Dynamics to $46 from $51 and for U.S. Steel to $33 from $34.
DGX Quest Diagnostics
$85.17

-0.55 (-0.64%)

04/02/19
04/02/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Exelon (EXC) upgraded to Outperform from Market Perform at Wells Fargo with analyst Neil Kalton saying a key tenant to his thesis is that ExGen's nuclear fleet operates through the end of the units' various license extension periods, which will likely require additional policy support. 2. CommScope (COMM) upgraded to Outperform from Neutral at Credit Suisse with analyst Sami Badri citing fundamental strength in the combined business computed in his updated CommScope-Arris (ARRS) merger model with the Arris acquisition expected to close in April 2019. 3. Quest Diagnostics (DGX) and LabCorp (LH) upgraded to Buy from Hold at Jefferies. 4. Hostess Brands (TWNK) upgraded to Buy from Hold at Deutsche Bank with analyst Rob Dickerson saying management execution, a turnaround to profitability in the Chicago bakery and improved pricing could return Hostess to "top-tier revenue growth" this year. 5. Amphenol (APH) upgraded to Buy from Hold at SunTrust with analyst William Stein saying in a world of uncertainty, Amphenol offers more dependable upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/02/19
WOLF
04/02/19
INITIATION
WOLF
Underperform
Quest Diagnostics initiated with an Underperform at Wolfe Research
Wolfe Research started Quest Diagnostics with an Underperform rating and $83 price target, citing concerns about the 2021 impact of PAMA and the view that almost all of its free cash flow is "spoken for" over the next few years.
04/02/19
JEFF
04/02/19
UPGRADE
Target $107
JEFF
Buy
Quest, LabCorp upgraded to Buy ahead of UnitedHealth lab network rollout
Jefferies analyst Brian Tanquilut upgraded both Quest Diagnostics (DGX) and Laboratory Corp. of America (LH) to Buy from Hold on the belief that UnitedHealth's (UNH) rollout on July 1 of its preferred lab network will be a positive catalyst for both stocks. Quest and LabCorp's likely inclusion should bolster their organic growth beginning in 2020, Tanquilut tells investors in a research note. The analyst finds both stocks "compelling" with their 2019 outlooks "seemingly de-risked with fairly conservative guidance ranges" and 2020 consensus estimates "looking conservative." Further, Quest's and LabCorp's valuations are at below-historical relative averages, Tanquilut contends. The analyst raised his price target for Laboratory Corp. to $190 from $154 and for Quest to $107 from $93.
04/02/19
JEFF
04/02/19
UPGRADE
JEFF
Buy
Quest Diagnostics upgraded to Buy from Hold at Jefferies
Jefferies analyst Brian Gil Tanquilut upgraded Quest Diagnostics to Buy from Hold.
HAS Hasbro
$88.02

-0.72 (-0.81%)

04/11/19
MKMP
04/11/19
NO CHANGE
Target $102
MKMP
Buy
Hasbro's Q1 to mark inflection point on Toys R Us headwinds, says MKM Partners
MKM Partners analyst Eric Handler kept his Buy rating and $102 price target on Hasbro, saying the company's Q1 should mark an inflection point for the company as the "last quarter where Toys R Us headwinds should have any impact on results." The analyst also expects the investor focus to shift to the company's "strong upcoming product lineup" and the possibility of improved financial performance in 2019. Handler adds that while Q1 may be impacted by a cautious retailer sentiment, he believes that Hasbro's inventory levels have reached a trough and that its order levels should improve amid "revamped distribution capabilities."
03/04/19
03/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Foot Locker (FL) upgraded to Buy from Hold at Pivotal Research with analyst Mitch Kummetz saying the company on Friday reported much better than expected Q4 results, and its fiscal 2019 same-store-sales and earnings growth outlook was also well above consensus. 2. Hasbro (HAS) upgraded to Market Perform from Underperform at BMO Capital with analyst Gerrick Johnson saying the stock's multiple will expand as "major theatrical events" approach later in the year. 3. Hertz (HTZ) upgraded to Buy from Neutral at Northcoast. 4. Extended Stay America (STAY) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Grambling citing the company's Q4 earnings report. 5. Kraft Heinz (KHC) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying he believes FY19 estimates now look achievable following their recent correction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/04/19
BMOC
03/04/19
UPGRADE
Target $88
BMOC
Market Perform
Hasbro upgraded to Market Perform from Underperform at BMO Capital
BMO Capital analyst Gerrick Johnson upgraded Hasbro to Market Perform from Underperform and raised his price target for the shares to $88 from $75. The stock's multiple will expand as "major theatrical events" approach later in the year, Johnson tells investors in a research note. He believes the shares have now entered the Frozen 2 "hype cycle." The movie releases on November 22, and Hasbro holds the master toy license with toys on shelf on October 4, the analyst points out. Further, relief that the Toys "R" US disruption of 2018 is over and a lowering of near-term financial expectations have "cleared the way for investor sentiment to improve," adds Johnson. The analyst, however, still sees risk to Hasbro's financials and believes the company could underperform Street expectations for 2019 and 2020.
03/21/19
WELS
03/21/19
NO CHANGE
Target $82
WELS
Market Perform
Hasbro price target lowered to $82 from $90 at Wells Fargo
Wells Fargo analyst Timothy Conder lowered his price target for Hasbro (HAS) to $82 from $90 as he expects shares to remain range-bound $80-$90 near-term as the company transitions through difficult Q1 comps, ongoing first half of 2019 European retail correction, and increased investment to support Magic Arena launch and product innovation. The analyst does not see many other near-term catalysts ahead of Q1 earnings mid-April, though there is some concern that Chairman/CEO Brian Goldner may leave for CBS (CBS). Conder reiterates a Market Perform rating on Hasbro's shares.
HOG Harley-Davidson
$39.71

-1.2 (-2.93%)

04/22/19
UBSW
04/22/19
NO CHANGE
Target $39
UBSW
Neutral
Harley-Davidson March retail sales seen down, says UBS
UBS analyst Robin Farley keeps her Neutral rating and $39 price target on Harley-Davidson saying its sales in March were likely down single digits, which brings the sales for Q1 to "down mid-single digits", even though the industry has "fared better". The analyst warns that the company's FY19 shipment guidance is at risk, anticipating a decline of 6% vs. the company's outlook of down 3%-5%.
04/08/19
WELS
04/08/19
DOWNGRADE
Target $41
WELS
Market Perform
Harley-Davidson risk/reward less attractive at current levels, says Wells Fargo
Wells Fargo analyst Timothy Conder downgraded Harley-Davidson to Market Perform from Outperform but raised his price target to $41 from $40, saying he believes risk/reward is now less attractive at current levels amid continued heavyweight motorcycle market weakness, tariff uncertainty and a "long" path to stabilization. Large heavyweight motorcycles, regardless of brand, remain challenged with ongoing new/used pricing and supply dynamics and a structural shift towards mid-size and smaller units, Conder says, adding that he believes Harley-Davidson's plans for mid-sized and small bikes, growing ridership and bringing in younger demographics to the brand and international expansion, collectively should provide a meaningful growth opportunity over time.
04/08/19
WELS
04/08/19
DOWNGRADE
WELS
Market Perform
Harley-Davidson downgraded to Market Perform from Outperform at Wells Fargo
04/03/19
LBOW
04/03/19
NO CHANGE
LBOW
Neutral
Polaris Industries estimates cut after dealer checks at Longbow
Longbow analyst David MacGregor lowered his first half of 2019 estimates for Polaris Industries (PII) after his dealer checks showed that off-road vehicle sales faced multiple headwinds in Q1, including weather, price increases, and increasing financing rates. Also, dealers said there was an "underwhelming response" to Polaris' Spring Sales Event, according to MacGregor, who keeps a Neutral rating on the stock. MacGregor added that he expects Harley-Davidson (HOG) again lost share in Q1 to Polaris' Indian motorcycle line.
PII Polaris Industries
$98.93

0.185 (0.19%)

01/15/19
LBOW
01/15/19
NO CHANGE
LBOW
Neutral
Longbow cuts Polaris Industries EPS estimates following end-of-quarter checks
Longbow analyst David MacGregor said in a note to investors prior to the open that his end-of quarter survey of Polaris dealer pointed to December ORV retail sales growth that was flat to up by a low single digit percentage in North America. He reduced his Q4 retail sales estimate to up low single digits following the checks and cut his EPS forecast to reflect lower ORV/Snowmobile shipments and his view that Polaris is on track to deliver below-consensus results. He keeps a Neutral rating on Polaris shares.
04/08/19
04/08/19
UPGRADE
Target $125

Overweight
Polaris Industries upgraded to Overweight on new product, tariffs at KeyBanc
As previously reported, KeyBanc analyst Brett Andress upgraded Polaris Industries to Overweight from Sector Weight, with a $125 price target. The analyst sees a favorable risk/reward developing given increased evidence that the company will meaningfully refresh its RZR line this year, driving outsized retail gains into FY20. Further, he believes Polaris Industries stands to benefit the most in his coverage should tariffs eventually make progress, providing additional optionality.
04/08/19
KEYB
04/08/19
UPGRADE
KEYB
Overweight
Polaris Industries upgraded to Overweight from Sector Weight at KeyBanc
JBLU JetBlue
$16.84

-0.13 (-0.77%)

04/02/19
SPHN
04/02/19
NO CHANGE
Target $63
SPHN
Overweight
Airlines needed some good news, and Delta delivered, says Stephens
With investor sentiment on the airline space negative, the group was in need of some good news and Delta Air Lines delivered a positive surprise this morning, Stephens analyst Jack Atkins tells investors in a research note. The airline pointed Q1 RASM growth to the upper-end of its initial guidance range, lowered its Q1 CASM excluding fuel expectation and raised its Q1 earnings guidance range, says the analyst. Atkins finds it encouraging that Delta noted underlying passenger demand remains solid and that the business market led the way during the quarter. Further, the company announced an extension of its credit card partnership with American Express (AXP), which is expected to double the revenue contribution to $7B by 2023 versus 2018 levels, he notes. Atkins reiterates an Overweight rating on Delta with a $63 price target. The stock in midday trading is up 7% to $55.64. Other names in the airline space include Alaska Air (ALK), American Airlines (AAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Continental (UAL).
03/11/19
LEHM
03/11/19
NO CHANGE
LEHM
Barclays upgrades Spirit to Overweight and names Top Pick, downgrades JetBlue
Barclays analyst Brandon Oglenski upgraded Spirit Airlines (SAVE) to Overweight from Equal Weight while downgrading JetBlue Airways (JBLU) to Equal Weight from Overweight. The analyst says that in a sector "besieged by seemingly permanent negative sentiment," he seeks airline managements "driving agendas and delivering tangible results." Improvements in network reliability, traction on revenue management initiatives, dynamic pricing of ancillary products and prime growth opportunities in the U.S. market suggest Spirit shares are "significantly undervalued," Oglenski tells investors in a research note. He expects the company's earnings growth will exceed 40% in 2019, and sees upside of over 35% in the shares. Oglenski names Spirit his Top Pick in airlines. For JetBlue, the analyst believes the company's commercial initiatives can be subject to competitive pressure. While there is a lot to like, the company is not seeing much traction, says Oglenski.
03/11/19
LEHM
03/11/19
DOWNGRADE
Target $20
LEHM
Equal Weight
JetBlue downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Brandon Oglenski downgraded JetBlue Airways to Equal Weight from Overweight and lowered his price target for the shares to $20 from $27.
GPK Graphic Packaging
$12.98

0.035 (0.27%)

01/04/19
UBSW
01/04/19
INITIATION
Target $12
UBSW
Neutral
Graphic Packaging initiated with a Neutral at UBS
UBS analyst Edlain Rodriguez initiated Graphic Packaging with a Neutral rating and $11.50 price target.
01/07/19
SBSH
01/07/19
UPGRADE
Target $27
SBSH
Buy
Silgan Holdings upgraded to Buy from Neutral at Citi
Citi analyst Anthony Pettinari upgraded Silgan Holdings (SLGN) to Buy with an unchanged price target of $27. The analyst says the upgrade reflects a more defensive positioning for Paper & Packaging in 2019. Following 2018's underperformance there are some supportive signs on valuation, with the Packagers' disconnect from Consumer Staples "especially noteworthy," Pettinari tells investors in a research note. Crown Holdings (CCK), Berry Global (BERY) and Graphic Packaging (GPK) are his top picks for 2019.
12/27/18
12/27/18
NO CHANGE

Stephens to keep GrubHub, RealPage, Vulcan Materials on 2019 Best Ideas list
Stephens said that it plans to publish a complete updated 2019 Best Ideas list on January 2, but in anticipation it shared the names that are being dropped and the three stocks that will remain on the list. The holdovers are GrubHub (GRUB), RealPage (RP) and Vulcan Materials (VMC). The stocks being removed include Boston Scientific (BSX), Brookdale Senior Living (BKD), Conn's (CONN), CoStar Group (CSGP), Curo Group (CURO), FedEx (FDX), First Financial Bancorp (FFBC), Graphic Packaging (GPK), Hub Group (HUBG), Keane Group (FRAC), KeyCorp (KEY), LKQ Corp. (LKQ), Myriad Genetics (MYGN), SVB Financial (SIVB), Triumph Bancorp (TBK), TrueCar (TRUE) and Union Bankshares (UBSH).
12/11/18
GHSC
12/11/18
INITIATION
GHSC
Neutral
Graphic Packaging initiated with a Neutral at Seaport Global
Seaport Global analyst Mark Weintraub initiated Graphic Packaging with a Neutral citing mixed catalysts as price improvement is being undercut by slippage in renewed sales contracts.

TODAY'S FREE FLY STORIES

T

AT&T

$31.79

0.17 (0.54%)

, CMCSA

Comcast

$43.54

0.29 (0.67%)

16:48
05/19/19
05/19
16:48
05/19/19
16:48
On The Fly
Box Office Battle: 'John Wick' beats 'Avengers: Endgame' with $57M opening »

"Box Office Battle" is…

T

AT&T

$31.79

0.17 (0.54%)

CMCSA

Comcast

$43.54

0.29 (0.67%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$52.65

0.85 (1.64%)

LGF.A

Lionsgate

$15.60

1.99 (14.62%)

DIS

Disney

$135.04

-0.46 (-0.34%)

VIAB

Viacom

$28.45

-0.09 (-0.32%)

VIA

Viacom

$33.33

-0.05 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 23

    May

  • 23

    May

  • 05

    Jun

  • 06

    Jun

  • 10

    Jun

  • 12

    Jun

  • 24

    Jun

  • 24

    Jul

F

Ford

$10.29

-0.1 (-0.96%)

, FCAU

Fiat Chrysler

$14.84

-0.01 (-0.07%)

16:11
05/19/19
05/19
16:11
05/19/19
16:11
Periodicals
Fiat Chrysler Ram gaining on GM, Ford pickups, WSJ reports »

The growing popularity of…

F

Ford

$10.29

-0.1 (-0.96%)

FCAU

Fiat Chrysler

$14.84

-0.01 (-0.07%)

GM

General Motors

$37.00

-0.36 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

  • 05

    Jun

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 23

    Oct

RMD

ResMed

$112.81

-0.635 (-0.56%)

16:07
05/19/19
05/19
16:07
05/19/19
16:07
Hot Stocks
ResMed reveals demographic, clinical factors affect adherence to PAP therapy »

ResMed revealed several…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

GOOGL

Alphabet Class A

$1,168.28

-15.39 (-1.30%)

, GOOG

Alphabet

$1,161.89

-16.89 (-1.43%)

13:48
05/19/19
05/19
13:48
05/19/19
13:48
Periodicals
Google suspends some business with Huawei, Reuters reports »

Alphabet's Google…

GOOGL

Alphabet Class A

$1,168.28

-15.39 (-1.30%)

GOOG

Alphabet

$1,161.89

-16.89 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 27

    Oct

BA

Boeing

$354.99

0.5 (0.14%)

13:28
05/19/19
05/19
13:28
05/19/19
13:28
Periodicals
Boeing says simulator software of 737 Max jets corrected, Reuters says »

Boeing has made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

XOM

Exxon Mobil

$75.91

-0.44 (-0.58%)

13:17
05/19/19
05/19
13:17
05/19/19
13:17
Periodicals
Exxon evacuates all foreign staff from Iraqi oilfield, Reuters says »

Exxon Mobil has evacuated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

TSN

Tyson Foods

$82.50

-0.48 (-0.58%)

, MCD

McDonald's

$199.20

-0.71 (-0.36%)

13:06
05/19/19
05/19
13:06
05/19/19
13:06
Periodicals
Meat prices set to climb amid swine fever, WSJ reports »

African swine fever,…

TSN

Tyson Foods

$82.50

-0.48 (-0.58%)

MCD

McDonald's

$199.20

-0.71 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$285.98

-1.87 (-0.65%)

13:02
05/19/19
05/19
13:02
05/19/19
13:02
Periodicals
Deutsche Bank staff saw suspicious activity in Trump account, NYTimes says »

Anti-money laundering…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$285.98

-1.87 (-0.65%)

DB

Deutsche Bank

$7.58

-0.08 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

12:51
05/19/19
05/19
12:51
05/19/19
12:51
Hot Stocks
The Medicines Co. announces interim results from ORION-3 extension study »

The Medicines Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

ACAD

Acadia

$24.97

-0.69 (-2.69%)

12:44
05/19/19
05/19
12:44
05/19/19
12:44
Hot Stocks
Acadia presents Phase 2 CLARITY results for Pimavanserin »

Acadia Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PINS

Pinterest

$26.69

0.68 (2.61%)

08:37
05/18/19
05/18
08:37
05/18/19
08:37
Periodicals
Pinterest committed 'cardinal sin' for newly public company, Barron's says »

Pinterest released its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSHB

KushCo Holdings

$0.00

(0.00%)

08:32
05/18/19
05/18
08:32
05/18/19
08:32
Periodicals
Pot paraphernalia companies taking hit from tariffs, Barron's says »

The U.S.-China trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

JWN

Nordstrom

$37.09

0.16 (0.43%)

08:24
05/18/19
05/18
08:24
05/18/19
08:24
Periodicals
Nordstrom stock a 'can't miss bargain.' Barron's says »

Nordstrom remains the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

NTDOY

Nintendo

$0.00

(0.00%)

, TTWO

Take-Two

$106.76

-0.81 (-0.75%)

08:10
05/18/19
05/18
08:10
05/18/19
08:10
Periodicals
Take-Two 'winning the game,' Barron's says »

Videogame stocks are down…

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$106.76

-0.81 (-0.75%)

DIS

Disney

$135.04

-0.46 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 24

    Jun

  • 13

    Nov

TPR

Tapestry

$30.78

-0.56 (-1.79%)

, REGN

Regeneron

$304.81

-4.69 (-1.52%)

08:01
05/18/19
05/18
08:01
05/18/19
08:01
Periodicals
Regeneron, Tapestry among cheap stocks to ride out trade war, Barron's says »

Applied Materials (AMAT),…

TPR

Tapestry

$30.78

-0.56 (-1.79%)

REGN

Regeneron

$304.81

-4.69 (-1.52%)

SCHW

Charles Schwab

$43.21

-0.94 (-2.13%)

BWA

BorgWarner

$36.27

-0.375 (-1.02%)

AMAT

Applied Materials

$42.72

-1.56 (-3.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 29

    May

  • 31

    May

  • 06

    Jun

  • 14

    Jun

  • 26

    Jun

  • 25

    Jul

MT

ArcelorMittal

$16.37

-0.485 (-2.88%)

, CLF

Cleveland-Cliffs

$10.02

-0.08 (-0.79%)

07:25
05/18/19
05/18
07:25
05/18/19
07:25
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

MT

ArcelorMittal

$16.37

-0.485 (-2.88%)

CLF

Cleveland-Cliffs

$10.02

-0.08 (-0.79%)

SCHN

Schnitzer Steel

$23.16

0.42 (1.85%)

BRSS

Global Brass and Copper

$43.09

-0.01 (-0.02%)

LXFR

Luxfer

$25.41

-0.44 (-1.70%)

MTRN

Materion

$66.36

0.155 (0.23%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$14.84

-0.01 (-0.07%)

F

Ford

$10.29

-0.1 (-0.96%)

GM

General Motors

$37.00

-0.36 (-0.96%)

HMC

Honda

$25.64

-0.135 (-0.52%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.40

-1.44 (-1.20%)

VWAGY

Volkswagen

$0.00

(0.00%)

SHOO

Steven Madden

$31.49

-0.37 (-1.16%)

GIII

G-III Apparel

$31.82

-0.35 (-1.09%)

IIVI

II-VI

$32.66

-1.64 (-4.78%)

LITE

Lumentum

$46.30

-4.15 (-8.23%)

MU

Micron

$36.06

-1.37 (-3.66%)

WDC

Western Digital

$44.62

-0.82 (-1.80%)

COHR

Coherent

$121.28

-5.22 (-4.13%)

LASR

nLight

$21.21

-1.27 (-5.65%)

VECO

Veeco

$12.50

-0.25 (-1.96%)

NPTN

NeoPhotonics

$3.83

-0.7 (-15.45%)

AAPL

Apple

$188.97

-0.93 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 28

    May

  • 29

    May

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 23

    Oct

WMT

Walmart

$100.88

-0.56 (-0.55%)

17:59
05/17/19
05/17
17:59
05/17/19
17:59
Hot Stocks
Walmart EVP Furner sells 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 15

    Aug

  • 13

    Nov

XOM

Exxon Mobil

$75.91

-0.44 (-0.58%)

, REPYY

Repsol

$0.00

(0.00%)

17:56
05/17/19
05/17
17:56
05/17/19
17:56
Periodicals
Exxon Gulf of Mexico sale gets interest from Repsol, Ineos, Bloomberg says »

Exxon Mobil (XOM) has…

XOM

Exxon Mobil

$75.91

-0.44 (-0.58%)

REPYY

Repsol

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 29

    May

IEF

iShares 7-10 Year Treasury Bond ETF

$106.74

0.04 (0.04%)

, SHY

iShares 1-3 Year Treasury Bond

$84.15

0.02 (0.02%)

17:43
05/17/19
05/17
17:43
05/17/19
17:43
General news
Weekly CFTC Commitment of Traders highlights »

2-YEAR U.S. TREASURY net…

IEF

iShares 7-10 Year Treasury Bond ETF

$106.74

0.04 (0.04%)

SHY

iShares 1-3 Year Treasury Bond

$84.15

0.02 (0.02%)

SPY

SPDR S&P 500 ETF Trust

$285.98

-1.87 (-0.65%)

SLV

iShares Silver Trust

$13.52

-0.14 (-1.02%)

GLD

SPDR Gold Shares

$120.64

-0.86 (-0.71%)

FXE

Euro Currency Trust

$106.35

-0.13 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$285.98

-1.87 (-0.65%)

17:39
05/17/19
05/17
17:39
05/17/19
17:39
Periodicals
IMF's Lagarde: U.S.-China trade spat may be risk to global economy, Reuters says »

IMF managing director…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$285.98

-1.87 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIG

Hartford Financial

$53.58

-0.02 (-0.04%)

17:34
05/17/19
05/17
17:34
05/17/19
17:34
Syndicate
Breaking Syndicate news story on Hartford Financial »

Hartford Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

AFH

Atlas Financial

$0.91

0.0225 (2.53%)

17:33
05/17/19
05/17
17:33
05/17/19
17:33
Hot Stocks
Atlas Financial receives filing delinquency notice from Nasdaq »

Atlas Financial received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WES

Western Gas Partners

$30.60

-0.155 (-0.50%)

17:29
05/17/19
05/17
17:29
05/17/19
17:29
Syndicate
Breaking Syndicate news story on Western Gas Partners »

Western Gas Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$354.99

0.5 (0.14%)

17:24
05/17/19
05/17
17:24
05/17/19
17:24
Hot Stocks
Boeing awarded $163.91M Navy contract modification »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

LMT

Lockheed Martin

$338.10

-2.39 (-0.70%)

17:18
05/17/19
05/17
17:18
05/17/19
17:18
Hot Stocks
Lockheed Martin subsidiary awarded $1.13B Navy contract modification »

Sikorsky, a Lockheed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.